QUANTUMONLINE.COM SECURITY DESCRIPTION: Harrow Health, Inc. 8.625% Senior Notes due 2026, redeemable at the issuer's option on or after 02/01/2026 at $25 per note plus accrued and unpaid interest, and maturing 04/30/2026. Interest distributions of 8.625% per annum ($2.15625 per annum or $0.5390625 per quarter) will be paid quarterly on 1/31, 4/30, 7/31 & 10/31 to holders of record on the record date that will be (NOTE: the ex-dividend date is one business day prior to the record date).
Distributions paid by these debt securities are interest and as such are NOT eligible for the preferential 15% to 20% tax rate on dividends and are also NOT eligible for the dividend received deduction for corporate holders.
This security was not rated by Moody’s or S&P at the time of its IPO. This security was rated as BB by Egan-Jones Ratings Co. at the date of its IPO. The Notes are unsecured and unsubordinated obligations of the company and will rank equally with all existing and future unsecured and unsubordinated indebtedness of the company. See the IPO prospectus for further information on the debt securities by clicking on the ‘Link to IPO Prospectus’ provided below.
